Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.93M | -3.93M | -4.17M | -4.17M | -5.29M |
| Total Depreciation and Amortization | 57.90K | 57.90K | 250.00K | 250.00K | 99.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.40M | 2.40M | 720.30K | 720.30K | 963.20K |
| Change in Net Operating Assets | -760.90K | -760.90K | -56.20K | -56.20K | -367.80K |
| Cash from Operations | -2.23M | -2.23M | -3.26M | -3.26M | -4.59M |
| Capital Expenditure | 0.00 | 0.00 | -600.00 | -600.00 | 7.90K |
| Sale of Property, Plant, and Equipment | 8.90K | 8.90K | -- | -- | 11.70K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 16.40K |
| Other Investing Activities | -300.00K | -300.00K | -225.00K | -225.00K | 75.00K |
| Cash from Investing | -291.10K | -291.10K | -225.60K | -225.60K | 110.90K |
| Total Debt Issued | -- | -- | -- | -- | 670.00K |
| Total Debt Repaid | -313.00K | -313.00K | -429.70K | -429.70K | -174.80K |
| Issuance of Common Stock | 2.36M | 2.36M | 1.77M | 1.77M | 6.62M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.04M | 2.04M | 1.34M | 1.34M | 7.12M |
| Foreign Exchange rate Adjustments | -31.90K | -31.90K | -16.40K | -16.40K | -9.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -511.00K | -511.00K | -2.16M | -2.16M | 2.63M |